Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2025.03.31
CHANGE IN COMPOSITION OF THE NOMINATION COMMITTEE
2025.03.28
ag真人平台官方：年度关联方资金占用专项审计报告
2025.03.28
ag真人平台官方：年度股东大会通知
2025.03.28
ag真人平台官方：内部控制自我评价报告
2025.03.28
ag真人平台官方：内部控制审计报告
2025.03.28
ag真人平台官方：关于修订第二期员工持股计划和第三期员工持股计划的公告
2025.03.28
ag真人平台官方：关于使用自有资金购买理财产品及进行现金管理的公告
2025.03.28
ag真人平台官方：关于开展以套期保值为目的的外汇衍生品交易的可行性分析报告
2025.03.28
ag真人平台官方：关于会计师事务所2024年度履职情况评估报告
2025.03.28
ag真人平台官方：关于公司2024年计提资产减值准备的公告
第一页
上一页
7
8
9
10
11
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
